Central serotonergic activity measured by citalopram challenge test and platelet monoamine oxidase activity, associations with gene polymorphism (5-HTTLPR) and impulsivity
- Conditions
- Healthy volunteers
- Registration Number
- EUCTR2004-005103-16-EE
- Lead Sponsor
- Estonian Science Foundation
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Authorised-recruitment may be ongoing or finished
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Healthy men and women, aged 20-55, volunteers, nonsmokers
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range
Exclusion Criteria
any mental or physical illnesses
Study & Design
- Study Type
- Interventional clinical trial of medicinal product
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Main Objective: Assessing central serotonergic activity by citalopram challenge test;Secondary Objective: ;Primary end point(s): prolactin level in venous blood
- Secondary Outcome Measures
Name Time Method